Detalles de la búsqueda
1.
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure).
Circ Res
; 122(12): 1703-1715, 2018 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703749
2.
Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
Circulation
; 135(15): 1417-1428, 2017 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28209728
3.
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.
Am Heart J
; 201: 54-62, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29910056
4.
Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.
Circ Res
; 116(1): 99-107, 2015 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25406300
5.
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial.
Am Heart J
; 179: 142-50, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27595689
6.
Bone marrow mononuclear cell therapy for acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
Circ Res
; 114(10): 1564-8, 2014 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-24812350
7.
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomes.
Circ Res
; 115(10): 867-74, 2014 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25136078
8.
Rationale and design for PACE: patients with intermittent claudication injected with ALDH bright cells.
Am Heart J
; 168(5): 667-73, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25440794
9.
Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
JAMA
; 307(16): 1717-26, 2012 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22447880
10.
Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
JAMA
; 308(22): 2380-9, 2012 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23129008
11.
Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
JAMA
; 306(19): 2110-9, 2011 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-22084195
12.
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Eur J Heart Fail
; 23(4): 661-674, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811444
13.
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design.
Am Heart J
; 160(2): 215-23, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20691824
14.
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.
JACC CardioOncol
; 2(4): 581-595, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33403362
15.
Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction.
Am Heart J
; 158(3): 356-63, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19699857
16.
Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: a replication and extension study.
Addict Behav
; 32(4): 875-80, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-16839698
17.
Moderators of delay tolerance in treatment-seeking cocaine users.
Addict Behav
; 32(2): 370-6, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16713126
18.
Illusory predictors: Generalizability of findings in cocaine treatment retention research.
Addict Behav
; 32(12): 2819-36, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17543472
19.
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN Trial.
Cell Transplant
; 25(9): 1675-1687, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26590374
20.
"Who gets in?" Recruitment and screening processes of outpatient substance abuse trials.
Addict Behav
; 29(2): 389-98, 2004 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-14732428